Identification of Site-specific Genome Alterations in Advanced Colorectal Cancer (SCRUM-Japan GI-screen 2013-01-CRC substudy 003)

Identification of Site-specific Genome Alterations in Advanced Colorectal Cancer (SCRUM-Japan GI-screen 2013-01-CRC substudy 003) - SCRUM-Japan GI-screen 2013-01-CRC substudy 003

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031242

Enrollment

1011

Registered

2018-02-10

Start date

2017-05-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients enrolled in SCRUM-Japan GI-Screen 2013-01-CRC from Feb. 2015 on, and whose cancer genome alterations were decided by OCP. 2)Patients who agreed to the secondary usage of specimen when they agreed to GI-Screen 2013-01-CRC, and did not revoked their agreements.

Exclusion criteria

Exclusion criteria: 1)Patients whose specimens were collected from metastatic site or unknown. 2)Patients who have administerd chemotherapy, including anti-EGFR therapies or anti-angiogenetic agents for metastatic disease before collecting the specimens. 3)Judged by the investigator to be inappropriate for study participation for any reason

Design outcomes

Primary

Measure	Time frame
site-specific gene mutation profiles in advanced colorectal cancer	—

Countries

Japan

Contacts

Public ContactTakuro Takuro

St. Marianna University School of Medicine Clinical Oncology

t3mizukami@marianna-u.ac.jp044-977-8111

Outcome results